Wacker Chemie AG’s 2025 Results Confirm a Weak Market Trajectory

Wacker Chemie AG, the Munich‑based specialty‑chemicals group, released preliminary figures for its 2025 financial year on 28 January 2026. The data show that the company has closed the year in a challenging environment, with declining sales and a sizeable operating loss – a result that has prompted a fresh “Hold” rating from Jefferies and a temporary dip in the share price.

Revenue and Earnings in a Downturn

The provisional numbers reveal a revenue of €5.49 billion, down from the previous year. The company’s EBITDA slipped to a loss of €1.27 billion – the most negative figure in its recent history. Operating income mirrored this trend, falling to €2.59 billion of loss. These figures are consistent with the narrative that Wacker faced “schwache Marktumfeld” (weak market environment) throughout 2025, as reported by multiple German financial outlets.

Despite the downturn, Wacker’s cash flow remained robust, with a positive free‑cash‑flow of €1.25 billion. The company’s management highlighted that its core businesses – hyper‑pure polysilicon for the electronics and solar sectors, semiconductor wafers, silicones, and vinyl‑acetate polymers – continue to generate stable cash streams even as global demand fluctuates.

Analyst Reaction and Market Sentiment

  • Jefferies has updated its recommendation to a “Hold” after the release of the provisional results. The firm cited the company’s strong balance sheet but noted that the operating loss and weaker revenue trend temper enthusiasm.
  • In the first trading session following the news, the share price rose by +3.84 % to €74.35 on Tradegate. However, by the end of the day the stock had slipped slightly, reflecting a cautious stance from investors amid a broader “träge Konjunktur” (sluggish economy) that has pressured many German manufacturers.
  • Other market watchers echoed the caution. The MDAX, which includes Wacker, recorded a modest decline of 0.61 % during the midday session, with Wacker’s shares among the most lightly impacted.

Long‑Term Outlook

Wacker’s management reiterated its commitment to cost‑efficiency and product innovation. The company’s strategic focus remains on expanding high‑margin specialty chemical lines, such as biotech products and advanced polymers, which are expected to cushion the company against cyclical demand swings. The balance sheet strength, highlighted by a healthy cash reserve, gives Wacker the flexibility to invest in research and development without compromising liquidity.

In summary, the provisional figures for 2025 confirm that Wacker Chemie AG is navigating a turbulent macro‑environment. While the company’s earnings have suffered, its cash position and strategic initiatives suggest a path toward resilience as market conditions gradually improve.